Bioverge, Inc. — Form C/A (Regulation Crowdfunding)
Bioverge, Inc. of SAN FRANCISCO, CA filed a Form C/A (Regulation Crowdfunding) with the SEC on 2023-06-16. Target raise $25K, up to $1.2M. Offered through OpenDeal Portal LLC.
Offering
- Filed: 2023-06-16
- Form: C/A
- Accession: 0001828649-23-000004
- Target amount: $25K
- Maximum amount: $1.2M
- Security type: Other
- Securities offered: 25,000
- Price: $1.0000
- Deadline: 2023-08-07
- Funding portal / intermediary: OpenDeal Portal LLC
- Intermediary file number: 007-00167
- Intermediary CRD: 283874
Issuer
- CIK: 0001828649
- Website: https://bioverge.com/
- Legal status: Corporation
- Organized in: DE
- Incorporated: 2017-08-17
- Address: 447 SUTTER ST, SAN FRANCISCO, CA, 94108
- Employees: 2
Financials (as filed)
- Total assets (most recent): $568K
- Cash (most recent): $324K
- Revenue (most recent): $248K
- Revenue (prior): $252K
- Net income (most recent): $-406K
- Net income (prior): $-592K
- Short-term debt: $53K
People (7)
| Name | Role | Location |
|---|
| Neil Littman | Board Member | San Francisco, CA |
| Neil Littman | Chief Executive Officer | San Francisco, CA |
| Neil Littman | President and CEO | San Francisco, CA |
| Neil Littman | Principal Accounting Officer | San Francisco, CA |
| Neil Littman | Principal Executive Officer | San Francisco, CA |
| Neil Littman | Principal Financial Officer | San Francisco, CA |
| Richard Gibb | COO | San Francisco, CA |
Reg CF filing history (14)
More